Airless dermal drug delivery technology offers safety, reliability, convenience and complete protection of the formulation. This article reviews the current state of the dermal drug delivery market and considers why Airless technology has yet to achieve the universal adoption that might be expected.
Benefits of the technology are discussed along with opportunities for brand differentiation, sustainability and customer choice. Key features of Aptar Pharma's dedicated Airless+ dermal drug delivery platform are examined along with associated options for digital healthcare solutions which can further improve patient outcomes. Airless technology provides a widely accepted, accessible solution for both topical and transdermal drug delivery.
This article reviews the current state of the dermal market and offers a macro environmental view, from both a consumer and regulatory perspective. It also discusses the benefits of Airless technology and the connected opportunities available to enhance patient adherence and support a vision of digital health for pharmaceutical companies, healthcare providers and consumers in the dermal space.